By Jeremy Geelan | Article Rating: |
|
March 31, 2011 11:34 PM EDT | Reads: |
23,922 |
Of all the "ists" in the world - artists, motorists, psychologists, anesthetists, equilibrists, whatever - the one type that probably everybody dreads in the very type I am due in just a few hours today to meet for the first time in my life: an oncologist.
Let me say this as gently as I can: no one wants to experience the kind of involuntary system re-boot that is involved whenever something as radical as Whipple surgery is involved. But Whipple patients still have a whole second challenge ahead of them: even if, as in my case, the surgery is completely successful, the recommended Next Steps involve chemo.
While not as debilitating as some other forms of chemotherapy, the drug Gemcitabine (a.k.a. GEMZAR) is most likely to become my new poison of choice. I won't know until the oncologist tells me how long the treatment will last, but I gather it may come in 21-day cycles. Given the proximity of Cloud Expo New York, I certainly hope the chemotherapy is a resounding success!
Meantime, I will continue to work even, if as in this photo, I have had to be creative at times...to avoid creasing my stomach where the scar from the Whipple operation is still knitting together only very slowly. Necessity, they say, is the mother of invention!
Read the original blog entry...
Published March 31, 2011 Reads 23,922
Copyright © 2011 SYS-CON Media, Inc. — All Rights Reserved.
Syndicated stories and blog feeds, all rights reserved by the author.
More Stories By Jeremy Geelan
Jeremy Geelan is Chairman & CEO of the 21st Century Internet Group, Inc. and an Executive Academy Member of the International Academy of Digital Arts & Sciences. Formerly he was President & COO at Cloud Expo, Inc. and Conference Chair of the worldwide Cloud Expo series. He appears regularly at conferences and trade shows, speaking to technology audiences across six continents. You can follow him on twitter: @jg21.
Apr. 23, 2018 11:15 PM EDT Reads: 2,809 |
By Elizabeth White ![]() Apr. 23, 2018 11:00 PM EDT Reads: 1,128 |
By Elizabeth White ![]() Apr. 23, 2018 11:00 PM EDT Reads: 6,423 |
By Liz McMillan ![]() Apr. 23, 2018 10:30 PM EDT Reads: 17,436 |
By Yeshim Deniz ![]() Apr. 23, 2018 09:45 PM EDT Reads: 6,861 |
By Liz McMillan ![]() Apr. 23, 2018 09:45 PM EDT Reads: 22,645 |
By Elizabeth White ![]() Apr. 23, 2018 07:00 PM EDT Reads: 6,026 |
By Liz McMillan ![]() Apr. 23, 2018 07:00 PM EDT Reads: 13,648 |
By Elizabeth White ![]() Apr. 23, 2018 05:45 PM EDT Reads: 5,838 |
By Elizabeth White Apr. 23, 2018 05:30 PM EDT Reads: 7,461 |
By Pat Romanski ![]() Apr. 23, 2018 04:15 PM EDT Reads: 7,042 |
By Pat Romanski Apr. 23, 2018 02:45 PM EDT Reads: 1,470 |
By Liz McMillan Apr. 23, 2018 02:15 PM EDT Reads: 1,788 |
By Elizabeth White Apr. 23, 2018 01:30 PM EDT Reads: 1,829 |
By Elizabeth White ![]() Apr. 23, 2018 01:15 PM EDT Reads: 4,128 |
By Yeshim Deniz ![]() Apr. 23, 2018 01:15 PM EDT Reads: 2,115 |
By Liz McMillan ![]() Apr. 23, 2018 12:00 PM EDT Reads: 5,290 |
By Liz McMillan ![]() Apr. 23, 2018 12:00 PM EDT Reads: 13,289 |
By Pat Romanski Apr. 23, 2018 12:00 PM EDT Reads: 2,424 |
By Elizabeth White ![]() Apr. 23, 2018 11:00 AM EDT Reads: 7,138 |